CDKN2A and esophageal squamous cell carcinoma: A total of 158 ESCC samples were analyzed for p16INK4A expression through immunohistochemistry, with 30 (19.0 %) and 128 (81.0 %) showing positive and negative expressions, respectively (Fig. 1).